UVEITIS DUE TO IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATED WITH CERTOLIZUMAB PEGOL. MULTICENTER STUDY OF 80 PATIENTS.
J. L. Martin-Varillas, L. Sanchez-Bilbao,V. Calvo-Rio,A. Adan,I. Hernanz Rodriguez,E. Beltran,S. Castro,P. Fanlo Mateo,A. Garcia Martos, I. Torre-Salaberri,M. Cordero-Coma,J. De Dios-Jimenez Aberasturi,A. Garcia-Aparicio, M. Hernandez-Garfella, A. Sanchez-Andrade, A. Garcia-Valle,R. Miguelez, O. Maiz,S. Rodriguez Montero, A. Urruticoechea-Arana,R. Veroz Gonzalez,A. Conesa,C. Fernandez-Carballido,V. Jovani,O. Martinez Gonzalez,P. Moya, S. Romero-Yuste,P. Rubio Munoz,E. Pena Sainz-Pardo,M. Garijo Bufort,J. L. Hernandez,R. Blanco ANNALS OF THE RHEUMATIC DISEASES（2022）
AI 理解论文
溯源树
样例
